Monograph

B01AD11 - Tenecteplase

Not porphyrinogenic

Rationale

Recombinant enzyme. No CYP-interactions.

Chemical description

Recombinant fibrinspecific plasminogen activator. Administered as infusion within 6 hours after heart infarction.

Similar drugs

Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Metalyse · Metalyse 10.000 units, poeder en oplosmiddel voor oplossing voor injectie · Metalyse 5.000 units, poeder voor oplossing voor injectie · Metalyse 8.000 units, poeder en oplosmiddel voor oplossing voor injectie

Belgium

Metalyse · Metalyse 10 000 U sol. inj. (pdr. + solv.) i.v. ser. préremplie flac. · Metalyse 5 000 U sol. inj. (pdr.) i.v. flac. · Metalyse 8 000 U sol. inj. (pdr. + solv.) i.v. ser. préremplie flac.

United Kingdom

Metalyse · Metalyse 10,000unit powder and solvent for solution for injection vials · Metalyse 5,000unit powder for solution for injection vials · Metalyse 8,000unit powder and solvent for solution for injection vials

Denmark